Nannoni, Stefania http://orcid.org/0000-0002-1825-1874
Sirimarco, Gaia
Cereda, Carlo W.
Lambrou, Dimitris
Strambo, Davide
Eskandari, Ashraf
Mosimann, Pascal J.
Wintermark, Max
Michel, Patrik
Funding for this research was provided by:
Schweizerische Herzstiftung
European Academy of Neurology
Article History
Received: 15 November 2018
Revised: 22 December 2018
Accepted: 24 December 2018
First Online: 4 January 2019
Compliance with ethical standards
:
: In the last 3 years, Prof. P. Michel received research grants from the Swiss Heart Foundation, Boehringer Ingelheim and BMS through his institution; speaker fees from Boehringer Ingelheim, Bayer, Daiichi Sankyo, Medtronic and Amgen; honoraria from scientific advisory boards from Boehringer Ingelheim, Bayer, Pfizer and BMS and consulting fees from Medtronic, Astra-Zeneca and Amgen. His institution (CHUV), receives all of the support for stroke education and research. Dr. G. Sirimarco served on scientific advisory boards for Amgen and Daiichi Sankyo. Dr. C.W. Cereda received research grants from the Swiss Heart Foundation, Advisory Board of Research (EOC) and Boehringer Ingelheim in the last 3 years through his institution; honoraria from scientific advisory boards from Boehringer Ingelheim, Bayer and Pfizer. The other authors report no conflicts of interest.
: Collection, analysis and publication of data in ASTRAL was approved by the institution’s ethical commission.